No Data
Express News | Needham Reiterates Buy on Arcellx, Maintains $81 Price Target
Arcellx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 64.42% Needham → $81 Reiterates Buy → Buy 05/07/2024 64.42% Needham → $81 Reiterates Buy → Buy
Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
Express News | Arcellx Shares Are Trading Lower After the Company Reported Q1 Financial Results
Buy Rating Affirmed for Arcellx Inc on Robust IMMagine-3 Study Prospects and Efficient Manufacturing
Buy Rating Justified for Arcellx Inc. Amidst Progress in Anito-cel's Clinical Development and Regulatory Milestones